Kyverna Therapeutics: sell signal, week 12
Kyverna Therapeutics climbs 3.1%, but sellers keep control of volume
Our view last week
Kyverna Therapeutics' sell signal keeps bouncing, but the character has shifted: after last week's 9% jump, this week closes up just 2.6%, with an indecisive last bar and sellers back in slight control — the distribution phase continues. On the daily chart the stock rebounded 5% off a touch on the 20-day EMA, in the 7.8 area. The short, now in its 11th week of management, sits at a 9.4% loss.
This week's summary
Kyverna Therapeutics stock rebounds for a third straight week, +3.1%, but the volume picture is getting sharper: sellers control 63% of trading, up from 56% last week. Money flow, which had been improving for a month, turned lower this week. On the daily chart the stock keeps carving out higher lows, from the 7 area to the 8.1 area. The Sell signal is now in week 12.
IQS Phase
52
ordinary
Signal Strength
2
decline fading out
Sizing
MINIMUM
Ranking
#84 / 93
US stocks
Trade P&L %
-12.72%
from signal to date, no stop loss
Rank position
ranks 84th among the 93 sell signals for US stocks in our ranking, with a signal strength of 2 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
KYTX belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content